Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $685.73 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $220.22 | 3 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $148.89 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $141.00 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.32 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $72.67 | 1 | $0 (2023) |
| ABBVIE INC. | $15.63 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.63 | 1 | ABBVIE INC. ($15.63) |
| 2023 | $171.28 | 2 | Gilead Sciences, Inc. ($98.61) |
| 2022 | $148.75 | 3 | Novo Nordisk Inc ($130.19) |
| 2020 | $23.83 | 1 | Gilead Sciences, Inc. ($23.83) |
| 2018 | $148.89 | 1 | Teva Pharmaceuticals USA, Inc. ($148.89) |
| 2017 | $177.35 | 2 | Novo Nordisk Inc ($90.03) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: VIROLOGY | ||||||
| 05/24/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $98.61 | General |
| Category: HCV | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $72.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $75.89 | General |
| Category: Diabetes | ||||||
| 05/05/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.56 | General |
| 03/29/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $54.30 | General |
| Category: Diabetes | ||||||
| 02/14/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.83 | General |
| 10/04/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $148.89 | General |
| Category: Central Nervous System | ||||||
| 11/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $87.32 | General |
| 02/23/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $90.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 95 | $3,219 | $802.34 |
| 2022 | 1 | 31 | 66 | $2,277 | $633.35 |
| 2021 | 2 | 77 | 141 | $3,517 | $993.41 |
| 2020 | 2 | 64 | 104 | $2,317 | $714.82 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 38 | 77 | $2,825 | $733.04 | 25.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 14 | 18 | $394.00 | $69.30 | 17.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 31 | 66 | $2,277 | $633.35 | 27.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 40 | 76 | $2,398 | $737.96 | 30.8% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 37 | 65 | $1,119 | $255.45 | 22.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 34 | 54 | $1,581 | $520.16 | 32.9% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 30 | 50 | $736.00 | $194.66 | 26.4% |
About Dr. Vasuki Nagaraj, MD
Dr. Vasuki Nagaraj, MD is a Family Medicine healthcare provider based in Nashua, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851477657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vasuki Nagaraj, MD has received a total of $685.73 in payments from pharmaceutical and medical device companies, with $15.63 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($685.73).
As a Medicare-enrolled provider, Nagaraj has provided services to 224 Medicare beneficiaries, totaling 406 services with total Medicare billing of $3,144. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Nashua, NH
- Active Since 10/27/2006
- Last Updated 06/09/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851477657
Products in Payments
- AJOVY (Drug) $148.89
- Epclusa (Drug) $98.61
- Tresiba (Drug) $90.03
- Ozempic (Drug) $75.89
- FARXIGA (Drug) $72.67
- Rybelsus (Drug) $54.30
- MAVYRET (Drug) $15.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Nashua
Mark Posnick, Do, DO
Family Medicine — Payments: $2,770
Dr. Debra Margolis, Do, DO
Family Medicine — Payments: $1,615
Dr. Deborah Dennis, M.d, M.D
Family Medicine — Payments: $461.44
Alice Yu
Family Medicine — Payments: $302.50
Dr. Chun Rui Zhao, Md, MD
Family Medicine — Payments: $256.33
Dr. Fran Yu, Md, MD
Family Medicine — Payments: $243.14